Biomatics Capital related stories
All articles and analysis
BlackThorn Therapeutics nets $14 mln Series ASouth San Francisco-based BlackThorn Therapeutics, a treatment developer for neurobehavioral disorders, has raised an additional $14 million in Series A funding. The investors in this round were GV and Biomatics Capital.
- Biomatics Capital raises $200 mln for debut fund
Biomatics Capital Partners has closed its inaugural fund at $200 million, according to an SEC filing https://www.sec.gov/Archives/edgar/data/1672431/000167243116000003/xslFormDX01/primary_doc.xml Based in Seattle, the venture firm was established by Boris Nikolic, a former science adviser to Bill Gates.
- Biomatics Capital files to raise $150 mln
Seattle-based Biomatics Capital Partners has filed to raise $150 million, according to a regulatory filing. The firm, which earlier this year invested in New York-based AiCure, was established by Boris Nikolic, who previously was a science adviser for Bill Gates, and Julie Sunderland, former director of program-related investments for the Bill & Melinda Gates Foundation.
- AiCure raises $12.25 mln
AiCure said Monday it raised $12.25 million in funding led by New Leaf Venture Partners. Also participating were Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates. New York-based AiCure is an artificial intelligence company.